Patient characteristics associated with high-risk methotrexate concentrations and toxicity.

Key Points

Key points are not available for this paper at this time.

Abstract

This study identified several clinical variables that influence MTX disposition that, when modified, can reduce the frequency of high-risk MTX concentrations and toxicity.

Bookmark

Cite This Study

Relling et al. (Mon,) studied this question.

synapsesocial.com/papers/69d782fcf07a12db70b8b278 https://doi.org/https://doi.org/10.1200/jco.1994.12.8.1667

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.1976 · 165 citations
2Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion1983 · 77 citations
3Classification and Regression Trees.1986 · 21,046 citations
4Recovery from toxicity associated with high-dose methotrexate: prognostic factors.1977 · 45 citations
5Reduced Citrovorum Factor Rescue for High-Dose Methotrexate Therapy in Childhood Malignancies1985 · 10 citations